Company Financials

Dermapharm Holding SE Financials

Euro

business Dermapharm Holding SE Company Profile

Main Stock Listing

FSX: DMP

Market Capitalization €1.87 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 18.10
Forward PE 13.47
Price to Sales TTM €1.56
Price to Book MRQ €2.93
Enterprise to Revenue 2.29
Enterprise to EBITDA 11.07

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 8.64%
Operating Margin 17.87%
Return on Assets TTM 6.40%
Return on Equity TTM 16.57%

Income Statement

Revenue TTM €1,199,297,024
Revenue per Share TTM €22.27
Quarterly Revenue Growth 1.30%
Gross Profit TTM €749,836,032
EBITDA €306,305,000
Net Income to Common TTM €103,573,000
Diluted EPS TTM €1.92
Quarterly Earnings Growth YoY -23.40%

Balance Sheet

Total Cash MRQ €115,176,000
Total Cash per Share MRQ €2.14
Total Debt MRQ
Total Debt to Equity MRQ 154.98
Current Ratio MRQ 2.06
Book Value per Share MRQ €11.85

Cash Flow

Operating Cash Flow TTM €172,510,000
Levered Free Cash Flow TTM €79,204,872

DMP Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 53,840,000
Float Shares 14,149,173
Avg 10 Volume 42
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 73.74%
% Held by Institutions 13.93%

Stock Price Summary

Beta 1.28
Fifty Two Week Low €29.90
Fifty Two Week High €42.15
Fifty Two Week Change -2.45%
Day 50 MA €36.24
Day 200 MA €36.65

Dividends and Splits

Forward Annual Dividend Rate €3.60
Forward Annual Dividend Yield 10.36%
Trailing Annual Dividend Rate €0.90
Trailing Annual Dividend Yield 2.59%
Payout Ratio 45.83%
Dividend Date
Ex Dividend Date 2025-06-27
Last Split Factor
Last Split Date